Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics – as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.

The Pandemic Sciences Institute has signed a memorandum of understanding with Institut Pasteur de Dakar (IPD) to become a partner institution. 

As a member of the Pasteur Network, IPD is a 100-year-old Senegalese institution dedicated to accelerating equitable access to healthcare. IPD is a leading public health and research institution actively engaged in pandemic preparedness, outbreak surveillance and response, and vaccine and diagnostics manufacturing. Through its Centre for Africa's Resilience to Epidemics (CARE) program and its laboratories, IPD supports African countries in building resilient capacities for early detection and rapid response to health threats.

The new three-year partnership aims to advance public health and life science collaboration in West Africa by leveraging the complementary strengths of PSI and IPD. 

Read the full story on the Pandemic Sciences Institute website.